Publications by authors named "R S Keizer"

Claim this Profile
M
Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.
Mike Wu, Daniël P de Bruyn, Ruben G Boers, Aaron B Beasley, Daan M Hazelaar, Ronald O B de Keizer

Cancer Cell Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study.
Gijsbert J Hötte, P Martijn Kolijn, Maaike de Bie, Sigrid M A Swagemakers, Peter J van der Spek, Ronald O B de Keizer

Invest Ophthalmol Vis Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing.
Wisse van Os, Amaury O'Jeanson, Carla Troisi, Chun Liu, Jordan T Brooks, Ron J Keizer

CPT Pharmacometrics Syst Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and sensitive bioassay for thyroid-stimulating immunoglobulin detection in thyrotropin-binding inhibitory immunoglobulin-negative euthyroid Graves' orbitopathy.
Gijsbert J Hötte, Madeleine Van der Burg, Willem A Dik, Maaike De Bie, Sodaba Khatab, Ronald O B De Keizer

Eur J Endocrinol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulated Dosing Regimens of Subcutaneous Infliximab in Adults and Children with Inflammatory Bowel Disease: Exploring Switch and Initiation Strategies.
Rianne A Weersink, Ron J Keizer, Luc J J Derijks

Eur J Drug Metab Pharmacokinet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis